People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

The FDA has granted accelerated approval to linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with ...

A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...

Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

AIM ImmunoTech Inc. (NYSE American: AIM) ('AIM” or the 'Company”) today announced a presentation and discussion on ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...

ImmunityBio, Inc. (NASDAQ:IBRX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. With ...